TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • February 20, 2020

SOMERSET, NJ—Catalent, a pharmaceutical CDMO, has purchased a Bristol-Myers Squibb (BMS) manufacturing and packaging facility in Anagni, Italy. The 305,000-square-foot facility’s capabilities include primary and secondary packaging solutions, including serialization, to support product launches for oral solid, sterile, and biologic products. Catalent will continue to manufacture the existing BMS product portfolio currently produced at the site.